Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus

被引:86
作者
Maiman, M
Fruchter, RG
Sedlis, A
Feldman, J
Chen, P
Burk, RD
Minkoff, H
机构
[1] SUNY Hlth Sci Ctr, Dept Obstet & Gynecol, Brooklyn, NY 11203 USA
[2] SUNY Hlth Sci Ctr, Dept Prevent Med, Brooklyn, NY 11203 USA
[3] SUNY Hlth Sci Ctr, Dept Pathol, Brooklyn, NY 11203 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA
关键词
D O I
10.1006/gyno.1998.4938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. The objective was to evaluate the sensitivity and specificity of cervical cytology in women infected with the human immunodeficiency virus (HIV), risk factors for abnormal cytology in HIV-infected and uninfected women, and risk factors for histologic diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-infected women. Methods. Methods included a cross-sectional analysis of cervical cytology, colposcopic impression, and histology in 248 HIV-infected women and multivariate analyses of risk factors for abnormal cytology in 253 HIV-infected and 220 uninfected women and risk factors for CIN in 186 HIV-infected women. Results. The sensitivity and specificity of cytology for all CIN grades were 0.60 and 0.80 and, for high-grade GIN, 0.83 and 0.74. The prevalence of abnormal cytology was 32.9% in HIV-infected and 7.6% in HIV-negative women. Independent risk factors for abnormal cytology were immunodeficiency [odds ratio (OR) 8-17, P < 0.001] and human papillomavirus (HPV) infection (OR = 5, P < 0.001). The prevalence of CIN on histology was 32% in HIV-infected women, and the only independent risk factor for CIN was oncogenic HPV type (OR = 5, P = 0.005). Conclusion. Given the high prevalence of abnormal cytology and CIN in HIV-infected women, cytologic screening has significant limitations. Both immunodeficiency and type of HPV infection are important risk factors. (C) 1998 Academic Press.
引用
收藏
页码:233 / 239
页数:7
相关论文
共 28 条
[1]   Natural history of low-grade squamous intraepithelial lesions in women infected with human immunodeficiency virus [J].
Belafsky, P ;
Clark, RA ;
Kissinger, P ;
Torres, J .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (05) :511-512
[2]  
BURK RD, 1996, J INFECT DIS, V174, P678
[3]  
CONTI M, 1991, ADV GYNECOL OBSTET R, V3, P283
[4]   ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE - INTERLABORATORY COMPARISON AND QUALITY ASSURANCE MONITORS [J].
DAVEY, DD ;
NARYSHKIN, S ;
NIELSEN, ML ;
KLINE, TS .
DIAGNOSTIC CYTOPATHOLOGY, 1994, 11 (04) :390-396
[5]   THE VALUE OF CERVICAL CYTOLOGY IN HIV-INFECTED WOMEN [J].
DELPRIORE, G ;
MAAG, T ;
BHATTACHARYA, M ;
GARCIA, PM ;
TILL, M ;
LURAIN, JR .
GYNECOLOGIC ONCOLOGY, 1995, 56 (03) :395-398
[6]   METAANALYSIS OF PAP TEST ACCURACY [J].
FAHEY, MT ;
IRWIG, L ;
MACASKILL, P .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) :680-689
[7]   THE ADEQUACY OF CYTOLOGY AND COLPOSCOPY IN DIAGNOSING CERVICAL NEOPLASIA IN HIV-SEROPOSITIVE WOMEN [J].
FINK, MJ ;
FRUCHTER, RG ;
MAIMAN, M ;
KELLY, P ;
SEDLIS, A ;
WEBBER, CA ;
CHEN, P .
GYNECOLOGIC ONCOLOGY, 1994, 55 (01) :133-137
[8]   Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus [J].
Fruchter, RG ;
Maiman, M ;
Sedlis, A ;
Bartley, L ;
Camilien, L ;
Arrastia, CD .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (03) :338-344
[9]   HIGH-FREQUENCY OF LATENT AND CLINICAL HUMAN PAPILLOMAVIRUS CERVICAL INFECTIONS IN IMMUNOCOMPROMISED HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN [J].
JOHNSON, JC ;
BURNETT, AF ;
WILLET, GD ;
YOUNG, MA ;
DONIGER, J .
OBSTETRICS AND GYNECOLOGY, 1992, 79 (03) :321-327
[10]  
KORN AP, 1994, OBSTET GYNECOL, V83, P401